Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Brazil

 

Ophthalmology: A birds eye view of a fragmented market

Ophthalmology may be a fragmented market, but international chains like Aier and Optegra are emerging. Can national operators build real competitive advantage in largely unconsolidated markets? And if so, how? HBI 2019 drew together CxOs from three large players as former ophthalmologist turned Mansfield Advisor Victor Chua chaired a session to find out more.
May 7, 2019

UnitedHealth’s Amil de-lists chunk of Brazil’s biggest hospital chain

Brazilian payor-provider Amil, owned by UnitedHealth, has partially or fully de-listed almost half of Rede D'Or's hospitals, the country's largest operator, while its president talks about "not referring patients to anyone who is wasting money". One local source thinks this is the beginning of a massive tussle between the two giants, while another says their size makes a swift compromise inevitable.
May 2, 2019

Vivisol acquires in Germany and Brazil

Italian medicalised homecare group Vivisol has acquired two companies in Germany and three in Brazil. We spoke to the vice president of Western European operations at HBI 2019.
April 12, 2019

Orpea advances in Latin America

Orpea, Europe's second-largest nursing home operator by revenue, has made big strides in Latin America, with acquisitions in Chile, Brazil and Uruguay in 2018. We speak to a market expert about its expansion, with a focus on Brazil, and its full-year results published this week.
March 28, 2019

Selling whole genome sequencing to consumers

Javier Echevarria, CEO, Europe and LatAm of Veritas International (VI) has one of the most interesting challenges in marketing - how do you persuade wealthy consumers to spend around $2,000 on predictive whole genome sequencing (WGS)?  He has a broad canvas - his remit is to sell across LatAm, UAE, Europe and Japan.
March 6, 2019

Rede d’Or to IPO in 2019?

Brazil's largest hospital group by revenue, Rede d'Or, has announced its expansion plans for the next five years. But given ongoing speculation about its plans to list, it seems likely to IPO well within this timeframe, perhaps even this year. HBI puts this to the company and talks to a market expert.
March 1, 2019

Brazilian telemedicine’s false start

Brazil's Federal Medical Council (CFM) has re-banned telemedicine just 19 days after it unbanned the practice. A well-connected source says it could take many months for the resolution to pass afresh. 
February 27, 2019

Brazilian healthcare reform: As easy as “changing a flat tyre on a moving car”

Despite widespread global criticism for his politics, president Jair Bolsonaro has inspired confidence in the private sector. The Brazilian stock market Bovespa reached record highs last week after climbing steadily for the last six months. Why is private healthcare not seeing more benefit, and how does it need to reform? We speak to two experts in Brazilian healthcare to find out more.
January 28, 2019
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us